Boji Medical Tech secures patent for tannic acid detection method

Boji Medical Technology Co., Ltd. (Boji Medical Tech) announced on September 20, 2025, that it has been granted an invention patent certificate by the National Intellectual Property Administration. The patent, with certificate number 8272934 and patent number ZL 2025 1 0318197.1, was applied for on March 18, 2025, and authorized for announcement on September 19, 2025.

The patented invention, titled "A method for determining gallic acid in tannic acid berberine," falls within the field of drug component detection. This method allows for the efficient separation of tannic acid, berberine, and gallic acid in tannic acid berberine, characterized by short detection times and high separation efficiency. It establishes a strong foundation for controlling the safety and stability of tannic acid berberine.

Boji Medical Tech stated that while the acquisition of this patent is not expected to significantly impact the company's current operating performance, it is beneficial for technological innovation. It strengthens the intellectual property protection system, leverages the company's proprietary intellectual property advantages, and fosters a continuous innovation mechanism, thereby enhancing core competitiveness.